ImportRefusal LogoImportRefusal

Degort's Chemical, S.A. de C.V.

⚠️ High Risk

FEI: 3005020284 • Ciudad De Mexico, Ciudad de Mexico • MEXICO

FEI

FEI Number

3005020284

📍

Location

Ciudad De Mexico, Ciudad de Mexico

🇲🇽

Country

MEXICO
🏢

Address

Calle Alhambra No. 310, Col. Portales Norte, Benito Juarez, Ciudad De Mexico, Ciudad de Mexico, Mexico

High Risk

FDA Import Risk Assessment

51.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

13
Total Refusals
3
Unique Violations
9/27/2022
Latest Refusal
12/7/2009
Earliest Refusal

Score Breakdown

Violation Severity
83.3×40%
Refusal Volume
42.5×30%
Recency
20.1×20%
Frequency
10.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7513×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
9/27/2022
65PDA02SILDENAFIL CITRATE (REGULATOR)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/22/2022
61XAK18DIPHENHYDRAMINE HCL (ANTI-HISTAMINIC)
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/23/2022
61XCY99ANTI-HISTAMINIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/19/2021
62GDY49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/30/2020
61XDY08CHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/2/2020
62GCA49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/22/2020
62GDA49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/18/2019
60FCA01KAOLIN (ADSORBANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/29/2019
60SCB23METOCLOPRAMIDE (ANTACID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/5/2018
60LCL99ANALGESIC, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/31/2017
60LCA01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/31/2017
65PCA02SILDENAFIL CITRATE (REGULATOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/7/2009
66VCA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Degort's Chemical, S.A. de C.V.'s FDA import refusal history?

Degort's Chemical, S.A. de C.V. (FEI: 3005020284) has 13 FDA import refusal record(s) in our database, spanning from 12/7/2009 to 9/27/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Degort's Chemical, S.A. de C.V.'s FEI number is 3005020284.

What types of violations has Degort's Chemical, S.A. de C.V. received?

Degort's Chemical, S.A. de C.V. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Degort's Chemical, S.A. de C.V. come from?

All FDA import refusal data for Degort's Chemical, S.A. de C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.